About This Deal

IDEX Corporation acquired Isolation Technologies, a transaction completed in October 2007, structured as all cash (asset acquisition). The deal was a Asset purchase.

Isolation Technologies operates in Health & Science Technologies, is based in Hopedale, Massachusetts, USA, had revenue of about approximately $12 million annual revenue. Leading developer of advanced column hardware and accessories for the High Performance Liquid Chromatography (HPLC) market; used in drug discovery and quality control for pharmaceutical and food/beverage testing. Headquartered in Hopedale, Massachusetts.

HST Core reporting unit within the Health and Science Technologies segment

Deal Terms

Acquirer
IDEX Corporation
Target
Isolation Technologies
Value
Not disclosed
Date
October 2007
Type
Asset purchase
Status
Ready

Transaction Details

Target HQ
Hopedale, Massachusetts, USA
Segment
Health & Science Technologies
Structure
All cash (asset acquisition)
Target revenue
Approximately $12 million annual revenue
Announced
October 18, 2007
Closed
October 18, 2007

In Their Words

On October 18, 2007, the Company acquired the assets of Isolation Technologies, a leading developer of advanced column hardware and accessories for the High Performance Liquid Chromatography (HPLC) market.

Advisors

Advisory firms were not disclosed for this transaction.

Related Deals & Entities

Sources: Press release ↗

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.